\-\ Texto\\:\\ \ \(0\)\
\-\ weakness\\ in\\ both\\ upper\\ and\\ lower\\ extremities\\,\\ right\\ greater\\ than\\ left\\.\ \(0\)\
\-\ multiple\\ lesions\\ within\\ the\\ brain\\.\\ the\\ most\\ prominent\\ were\\ in\\ the\\ left\\ frontal\\ and\\ parietal\\ region\\.\\ the\\ lesions\\ were\\ very\\ hyperintense\\ on\\ t2\\,\\ and\\ demonstrated\\ only\\ peripheral\\ enhancement\ \(0\)\
\-\ chondrosarcoma\\ metastatic\\ to\\ brain\ \(0\)\
\-\ given\\ the\\ marked\\ hyperintensity\\ on\\ t2\\ and\\ history\\ of\\ chondrosarcoma\\,\\ this\\ is\\ the\\ most\\ likely\\ diagnosis\\.\\ \\ metastases\\ from\\ other\\ locations\\ could\\ also\\ be\\ in\\ the\\ differential\\.\ \(0\)\
\-\ 55\\ yo\\ woman\\ with\\ history\\ of\\ a\\ resected\\ left\\ lower\\ extremity\\ chondrosarcoma\\.\\ \\ known\\ to\\ have\\ lung\\ metastases\\,\\ she\\ presents\\ now\\ with\\ right\\ upper\\ and\\ lower\\ extremity\\ weakness\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.11978197126251854\ \(0\)\
\-\ metastases\\:\\ 0\\.0682379897204296\ \(0\)\
\-\ weakness\\:\\ 0\\.059319838374362326\ \(0\)\
\-\ extremity\\:\\ 0\\.05841418634845678\ \(0\)\
\-\ lower\\:\\ 0\\.05388398325319241\ \(0\)\
\-\ brain\\:\\ 0\\.04806264529537872\ \(0\)\
\-\ locations\\:\\ 0\\.04660632735960189\ \(0\)\
\-\ t2\\:\\ 0\\.045207266705614056\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.04396864074573072\ \(0\)\
\-\ lesions\\:\\ 0\\.042758140305494345\ \(0\)\
\-\ resected\\:\\ 0\\.03953785930183108\ \(0\)\
\-\ 55\\:\\ 0\\.03871672513555693\ \(0\)\
\-\ upper\\:\\ 0\\.03854356084801342\ \(0\)\
\-\ most\\:\\ 0\\.03687542320987058\ \(0\)\
\-\ were\\:\\ 0\\.03626703433065273\ \(0\)\
\-\ parietal\\:\\ 0\\.0341189948602148\ \(0\)\
\-\ hyperintense\\:\\ 0\\.033155703410309996\ \(0\)\
\-\ prominent\\:\\ 0\\.03277804417350741\ \(0\)\
\-\ extremities\\:\\ 0\\.031324174008793344\ \(0\)\
\-\ marked\\:\\ 0\\.031167098136677632\ \(0\)\
\-\ greater\\:\\ 0\\.029997349137107485\ \(0\)\
\-\ could\\:\\ 0\\.029463158353556562\ \(0\)\
\-\ very\\:\\ 0\\.02898865063978625\ \(0\)\
\-\ peripheral\\:\\ 0\\.028896573102935672\ \(0\)\
\-\ given\\:\\ 0\\.02737770460295647\ \(0\)\
\-\ now\\:\\ 0\\.027300145698146237\ \(0\)\
\-\ left\\:\\ 0\\.026806689792698544\ \(0\)\
\-\ differential\\:\\ 0\\.025354764760307753\ \(0\)\
\-\ known\\:\\ 0\\.025271505462278687\ \(0\)\
\-\ frontal\\:\\ 0\\.025086840509190255\ \(0\)\
\-\ yo\\:\\ 0\\.02403132264768936\ \(0\)\
\-\ only\\:\\ 0\\.024013193069952667\ \(0\)\
\-\ demonstrated\\:\\ 0\\.023433831611747356\ \(0\)\
\-\ lung\\:\\ 0\\.023132328226530337\ \(0\)\
\-\ region\\:\\ 0\\.022557020815320676\ \(0\)\
\-\ likely\\:\\ 0\\.02252607444799679\ \(0\)\
\-\ she\\:\\ 0\\.02241856206966516\ \(0\)\
\-\ history\\:\\ 0\\.022060084816954827\ \(0\)\
\-\ enhancement\\:\\ 0\\.021406437066570427\ \(0\)\
\-\ than\\:\\ 0\\.020925690232881062\ \(0\)\
\-\ both\\:\\ 0\\.020394392436318888\ \(0\)\
\-\ metastatic\\:\\ 0\\.020103826202019535\ \(0\)\
\-\ woman\\:\\ 0\\.01844769109802716\ \(0\)\
\-\ other\\:\\ 0\\.0184078369037612\ \(0\)\
\-\ diagnosis\\:\\ 0\\.018338498418508594\ \(0\)\
\-\ have\\:\\ 0\\.017293813816496185\ \(0\)\
\-\ right\\:\\ 0\\.016852929142250776\ \(0\)\
\-\ multiple\\:\\ 0\\.016820616854946437\ \(0\)\
\-\ presents\\:\\ 0\\.016314432668298372\ \(0\)\
\-\ also\\:\\ 0\\.015744108352057487\ \(0\)\
\-\ within\\:\\ 0\\.015234872975570855\ \(0\)\
\-\ on\\:\\ 0\\.013530673128325758\ \(0\)\
\-\ be\\:\\ 0\\.012315483395737655\ \(0\)\
\-\ from\\:\\ 0\\.011835847786487965\ \(0\)\
\-\ in\\:\\ 0\\.011814875611409016\ \(0\)\
\-\ \\,\\:\\ 0\\.010120002449244388\ \(0\)\
\-\ the\\:\\ 0\\.009044345728274584\ \(0\)\
\-\ this\\:\\ 0\\.008982590778636756\ \(0\)\
\-\ and\\:\\ 0\\.008411635781879367\ \(0\)\
\-\ to\\:\\ 0\\.007982581466224041\ \(0\)\
\-\ is\\:\\ 0\\.005255054003595566\ \(0\)\
\-\ a\\:\\ 0\\.003706540203912161\ \(0\)\
\-\ \\.\\:\\ 0\\.0023223995577703166\ \(0\)\
\-\ with\\:\\ 0\\.0021869939456054155\ \(0\)\
\-\ of\\:\\ 0\\.0021776411364109985\ \(0\)\
